Launch week offerEnds in00h00m00s

Frédéric Ebstein

Group Leader

Université de Nantes
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Year:

2024

Year:

2024

Year:

2023

A critical step in preserving protein homeostasis is the recognition, binding, unfolding, and translocation of protein substrates by six AAA-ATPase proteasome subunits (ATPase-associated with various cellular activities) termed PSMC1-6, which are required for degradation of proteins by 26 S proteasomes. Here, we identified 15 de novo missense variants in the PSMC3 gene encoding the AAA-ATPase proteasome subunit PSMC3/Rpt5 in 23 unrelated heterozygous patients with an autosomal dominant form of neurodevelopmental delay and intellectual disability. Expression of PSMC3 variants in mouse neuronal cultures led to altered dendrite development, and deletion of the PSMC3 fly ortholog Rpt5 impaired reversal learning capabilities in fruit flies. Structural modeling as well as proteomic and transcriptomic analyses of T cells derived from patients with PSMC3 variants implicated the PSMC3 variants in proteasome dysfunction through disruption of substrate translocation, induction of proteotoxic stress, and alterations in proteins controlling developmental and innate immune programs. The proteostatic perturbations in T cells from patients with PSMC3 variants correlated with a dysregulation in type I interferon (IFN) signaling in these T cells, which could be blocked by inhibition of the intracellular stress sensor protein kinase R (PKR). These results suggest that proteotoxic stress activated PKR in patient-derived T cells, resulting in a type I IFN response. The potential relationship among proteosome dysfunction, type I IFN production, and neurodevelopment suggests new directions in our understanding of pathogenesis in some neurodevelopmental disorders.

Year:

2023

Collaborators (8)

Geeske van Woerden

Associate professor

Erasmus University Rotterdam

NETHERLANDS
View details

Marie-Pierre Bousquet

Institute of Pharmacology and Structural Biology

FRANCE
View details

Odile Schiltz

-

FRANCE
View details

Stéphane Bézieau

Université de Nantes

FRANCE
View details

Frederic Laumonnier

Team Leader, Research Director

INSERM

FRANCE
View details

Elke Krueger

Director

University Medicine Greifswald

GERMANY
View details

Dušan Živković

University of Oxford

UNITED KINGDOM
View details

Julien Marcoux

CNRS Research Director

Institute of Pharmacology and Structural Biology

FRANCE
View details